Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Anti-HCV screening and plasma fractionation: the case against.

× No keyword cloud information.

8 in total

Review 1. Safety and availability of immunoglobulin replacement therapy in relation to potentially transmissable agents. IUIS Committee on Primary Immunodeficiency Disease. International Union of Immunological Societies.

Authors: H M Chapel
Journal: Clin Exp Immunol Date: 1999-10 Impact factor: 4.330

Review 2. Human Immunoglobulins for intravenous use and hepatitis C viral transmission.

Authors: H B Slade
Journal: Clin Diagn Lab Immunol Date: 1994-11

Review 3. Managing occupational risks for hepatitis C transmission in the health care setting.

Authors: David K Henderson
Journal: Clin Microbiol Rev Date: 2003-07 Impact factor: 26.132

Review 4. Hepatitis C virus. A review.

Authors: E Tang
Journal: West J Med Date: 1991-08

5. Neutralizing antibodies to hepatitis C virus (HCV) in immune globulins derived from anti-HCV-positive plasma.

Authors: Mei-ying W Yu; Birke Bartosch; Pei Zhang; Zheng-ping Guo; Paula M Renzi; Li-Ming Shen; Christelle Granier; Stephen M Feinstone; François-Loïc Cosset; Robert H Purcell
Journal: Proc Natl Acad Sci U S A Date: 2004-05-10 Impact factor: 11.205

6. Immunoglobulin preparations from hepatitis C antibody-positive plasma donors: influence on diagnosis and risk of infection in heart transplant recipients.

Authors: W Prohaska; C Wolff; K Schlüter; W Köster-Eiserfunke; M M Körner; K Kleesiek
Journal: Clin Investig Date: 1992-07

Review 7. Adverse effects of intravenous immunoglobulin.

Authors: S A Misbah; H M Chapel
Journal: Drug Saf Date: 1993-10 Impact factor: 5.606

Review 8. Manufacture of immunoglobulin products for patients with primary antibody deficiencies - the effect of processing conditions on product safety and efficacy.

Authors: Albert Farrugia; Isabella Quinti
Journal: Front Immunol Date: 2014-12-23 Impact factor: 7.561

8 in total